Her work at Wellcome has also included leading the development of our vaccines strategy, overseeing the funding response to the West African Ebola epidemic, helping to co-found CEPI, the Coalition for Epidemic Preparedness Innovations, and developing strategic thinking about future epidemic preparedness.
Before joining Wellcome, Charlie worked at Novartis as a lab head for respiratory exacerbations. She also worked at Imperial College London for eight years as Asthma UK post-doctoral Fellow. Charlie has a PhD in Immunology from Imperial College London and an MPhil and BSc in genetics from the University of Birmingham.